NGM Biopharmaceuticals Inc (NGM): Eigentümerstruktur Nicht notiert
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name NGM Biopharmaceuticals Inc
Mitarbeiter 138
Handelsplatz NASDAQ
Ticker Symbol NGM
IPO Datum 2019-04-04
Adresse 333 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.ngmbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. William J. Rieflin J.D. | Executive Chairman of the Board of Directors |
| 2 | Dr. David J. Woodhouse Ph.D. | CEO & Director |
| 3 | Ms. Valerie L. Pierce J.D. | Senior VP, General Counsel, Secretary & Chief Compliance Officer |
| 4 | Dr. Hsiao Dee Lieu F.A.C.C., M.D. | Chief Medical Officer & Executive VP |
| 5 | Jean Frederic Viret Ph.D. | Chief Financial Officer |
| 6 | Ms. Irene Perlich | VP, Corporate Controller & Principal Accounting Officer |
| 7 | Mr. Daniel Kaplan Ph.D. | Chief Scientific Officer |
| 8 | Mahi Saraf | Director of People & Culture |
| 9 | Diana Peng Bockus | Head of Business Development |
| 10 | Arthur Hsu Ph.D. | Senior Director & Head of Biology |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Column Group LLC | 21,73% | 27,93 Mio. USD |
| 2 | BlackRock Inc | 3,60% | 4,63 Mio. USD |
| 3 | Vanguard Group Inc | 2,79% | 3,58 Mio. USD |
| 4 | StepStone Group LLC | 1,89% | 2,42 Mio. USD |
| 5 | Euclidean Capital LLC | 1,19% | 1,53 Mio. USD |
| 6 | Geode Capital Management, LLC | 1,18% | 1,52 Mio. USD |
| 7 | Trium Capital LLP | 1,17% | 1,51 Mio. USD |
| 8 | State Street Corporation | 0,99% | 1,27 Mio. USD |
| 9 | ADAR1 Capital Management LLC | 0,98% | 1,26 Mio. USD |
| 10 | Renaissance Technologies Corp | 0,73% | 0,94 Mio. USD |
| 11 | Two Sigma Advisers, LLC | 0,61% | 0,78 Mio. USD |
| 12 | Northern Trust Corp | 0,45% | 0,57 Mio. USD |
| 13 | Balyasny Asset Management LLC | 0,43% | 0,56 Mio. USD |
| 14 | Charles Schwab Investment Management Inc | 0,34% | 0,44 Mio. USD |
| 15 | Goldman Sachs Group Inc | 0,25% | 0,32 Mio. USD |
| 16 | Exchange Traded Concepts, LLC | 0,22% | 0,29 Mio. USD |
| 17 | Natixis SA | 0,22% | 0,28 Mio. USD |
| 18 | BNP Paribas Arbitrage, SA | 0,21% | 0,26 Mio. USD |
| 19 | Morgan Stanley - Brokerage Accounts | 0,19% | 0,24 Mio. USD |
| 20 | Dimensional Fund Advisors, Inc. | 0,19% | 0,24 Mio. USD |